Literature DB >> 11989648

Carcinogenic and nephrotoxic alkaloids aristolochic acids upon activation by NADPH : cytochrome P450 reductase form adducts found in DNA of patients with Chinese herbs nephropathy.

M Stiborová1, M Hájek, E Frei, H H Schmeiser.   

Abstract

Aristolochic acid (AA), a naturally occurring nephrotoxin and carcinogen, has been found to be implicated in an unique type of renal fibrosis, designated Chinese herbs nephropathy (CHN), and associated with the development of urothelial cancer in CHN patients. Understanding, which enzymes are involved in AA activation and/or detoxication is important in the assessment of individual susceptibility of humans to this natural carcinogen. Using the nuclease P1 version of the 32P-postlabeling assay we examined the ability of microsomal NADPH: CYP reductase to activate AA to metabolites forming DNA adducts. Renal and hepatic microsomes, containing NADPH:CYP reductase, generated AA-DNA adduct patterns reproducing those found in renal tissues in patients suffering from a renal fibrosis CHN and urothelial cancer. 7-(Deoxyadenosin-N6-yl)aristolactam I, 7-(deoxyguanosin-N2-yl)aristolactam I and 7-(deoxyadenosin-N6-yl)aristolactam II were identified as AA-DNA adducts formed by AAI. Two AA-DNA adducts, 7-(deoxyguanosin-N2-yl) aristolactam II and 7- (deoxyadenosin-N6-yl) aristolactam II, were generated from AAII. According to the structures of the DNA adducts identified, nitroreduction is the crucial pathway in the metabolic activation of AA. The identity of NADPH: CYP reductase as activating enzyme in microsomes has been proved with different cofactors and an enzyme inhibitor. Alpha-lipoic acid, a selective inhibitor of NADPH: CYP reductase, significantly decreased the amount of the adducts formed by microsomes. Likewise, only a cofactor of the enzyme, NADPH, supported the DNA adduct formation of AAI and AAII, while NADH was ineffective. These results demonstrate an involvement of NADPH: CYP reductase in the activation pathway of AAI and AAII in the microsomal system. Moreover, using the purified enzyme, the participation of this enzyme in the formation of AA-DNA adducts was confirmed. The results presented here are the first report demonstrating a reductive activation of natural nitroaromatic compounds, AA, by NADPH: CYP reductase.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11989648

Source DB:  PubMed          Journal:  Gen Physiol Biophys        ISSN: 0231-5882            Impact factor:   1.512


  13 in total

Review 1.  Biological reactive intermediates (BRIs) formed from botanical dietary supplements.

Authors:  Birgit M Dietz; Judy L Bolton
Journal:  Chem Biol Interact       Date:  2010-10-21       Impact factor: 5.192

2.  Botanical dietary supplements gone bad.

Authors:  Birgit Dietz; Judy L Bolton
Journal:  Chem Res Toxicol       Date:  2007-03-16       Impact factor: 3.739

3.  Genetic loci that affect aristolochic acid-induced nephrotoxicity in the mouse.

Authors:  Thomas A Rosenquist
Journal:  Am J Physiol Renal Physiol       Date:  2011-03-23

4.  Cytochrome P450 1A2 detoxicates aristolochic acid in the mouse.

Authors:  Thomas A Rosenquist; Heidi J Einolf; Kathleen G Dickman; Lai Wang; Amanda Smith; Arthur P Grollman
Journal:  Drug Metab Dispos       Date:  2010-02-17       Impact factor: 3.922

5.  Detoxification of aristolochic acid I by O-demethylation: less nephrotoxicity and genotoxicity of aristolochic acid Ia in rodents.

Authors:  Shinya Shibutani; Radha R Bonala; Thomas Rosenquist; Robert Rieger; Naomi Suzuki; Francis Johnson; Frederick Miller; Arthur P Grollman
Journal:  Int J Cancer       Date:  2010-09-01       Impact factor: 7.396

6.  Contribution of biotransformation enzymes to the development of renal injury and urothelial cancer caused by aristolochic acid: urgent questions, difficult answers.

Authors:  Marie Stiborová; Jiří Hudeček; Eva Frei; Heinz H Schmeiser
Journal:  Interdiscip Toxicol       Date:  2008-06

7.  Active Site Mutations as a Suitable Tool Contributing to Explain a Mechanism of Aristolochic Acid I Nitroreduction by Cytochromes P450 1A1, 1A2 and 1B1.

Authors:  Jan Milichovský; František Bárta; Heinz H Schmeiser; Volker M Arlt; Eva Frei; Marie Stiborová; Václav Martínek
Journal:  Int J Mol Sci       Date:  2016-02-05       Impact factor: 5.923

Review 8.  Balkan endemic nephropathy: an update on its aetiology.

Authors:  Marie Stiborová; Volker M Arlt; Heinz H Schmeiser
Journal:  Arch Toxicol       Date:  2016-08-19       Impact factor: 5.153

9.  Impact of genetic modulation of SULT1A enzymes on DNA adduct formation by aristolochic acids and 3-nitrobenzanthrone.

Authors:  Volker M Arlt; Walter Meinl; Simone Florian; Eszter Nagy; Frantisek Barta; Marlies Thomann; Iveta Mrizova; Annette M Krais; Maggie Liu; Meirion Richards; Amin Mirza; Klaus Kopka; David H Phillips; Hansruedi Glatt; Marie Stiborova; Heinz H Schmeiser
Journal:  Arch Toxicol       Date:  2016-08-24       Impact factor: 5.153

Review 10.  Mechanisms of enzyme-catalyzed reduction of two carcinogenic nitro-aromatics, 3-nitrobenzanthrone and aristolochic acid I: Experimental and theoretical approaches.

Authors:  Marie Stiborová; Eva Frei; Heinz H Schmeiser; Volker M Arlt; Václav Martínek
Journal:  Int J Mol Sci       Date:  2014-06-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.